When the logarithm of the Klotho/FGF-23 ratio was examined, we also found a highly significant increase in patients allocated to dapagliflozin ( Figure 2C ).
← all excerpts
Short-term changes in klotho and FGF23 in heart failure with reduced ejection fraction-a substudy of the DAPA-VO<sub>2</sub> study.
1
—
—